European clinical guidelines for hyperkinetic disorder -- first upgrade
Related Experiment Video
Updated: Aug 22, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Eric Taylor1, Manfred Döpfner, Joseph Sergeant
1Dept. of Child & Adolescent Psychiatry, Institute of Psychiatry Kings College London, de Crespigny Park, London, SE5 8AF, UK. e.taylor@iop.kcl.ac.uk
Background:
The validity of clinical guidelines changes over time, because new evidence-based knowledge and experience develop.
Objective:
Hence, the European clinical guidelines on hyperkinetic disorder from 1998 had to be evaluated and modified.
Method:
Discussions at the European Network for Hyperkinetic Disorders (EUNETHYDIS) and iterative critique of each clinical analysis. Guided by evidence-based information and based on evaluation (rather than metaanalysis) of the scientific evidence a group of child psychiatrists and psychologists from several European countries updated the guidelines of 1998. When reliable information is lacking the group gives a clinical consensus when it could be found among themselves.
Results:
The group presents here a set of recommendations for the conceptualization and management of hyperkinetic disorder and attention deficit/hyperactivity disorder (ADHD).
Conclusion:
A general scheme for practice in Europe could be provided, on behalf of the European Society for Child and Adolescent Psychiatry (ESCAP).
More Related Videos
13:09Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone ll
Huntington Disease l: Introduction
Alterations in Muscle Tone lll
Parkinson's Disease: Overview